Literature DB >> 28507399

Managing hepatitis C in general practice.

Simone I Strasser1.   

Abstract

Keywords:  antiviral drugs; cirrhosis; hepatitis C

Year:  2017        PMID： 28507399      PMCID： PMC5408001          DOI： 10.18773/austprescr.2017.017

Source DB:  PubMed          Journal:  Aust Prescr        ISSN： 0312-8008


× No keyword cloud information.
  4 in total

Review 1.  Australian Liver Association (ALA) expert consensus recommendations for the use of transient elastography in chronic viral hepatitis.

Authors:  William Kemp; Miriam Levy; Martin Weltman; John Lubel
Journal:  J Gastroenterol Hepatol       Date:  2015-03       Impact factor: 4.029

2.  Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection.

Authors:  Leon A Adams; Max Bulsara; Enrico Rossi; Bastiaan DeBoer; David Speers; Jacob George; James Kench; Geoffrey Farrell; Geoffrey W McCaughan; Gary P Jeffrey
Journal:  Clin Chem       Date:  2005-07-28       Impact factor: 8.327

3.  Enhanced antiviral treatment efficacy and uptake in preventing the rising burden of hepatitis C-related liver disease and costs in Australia.

Authors:  William Sievert; Homie Razavi; Chris Estes; Alexander J Thompson; Amany Zekry; Stuart K Roberts; Gregory J Dore
Journal:  J Gastroenterol Hepatol       Date:  2014-08       Impact factor: 4.029

4.  The Australasian Hepatology Association consensus guidelines for the provision of adherence support to patients with hepatitis C on direct acting antivirals.

Authors:  Jacqueline A Richmond; Suzanne Sheppard-Law; Susan Mason; Sherryne L Warner
Journal:  Patient Prefer Adherence       Date:  2016-12-13       Impact factor: 2.711
  4 in total
  2 in total

1.  Safety concerns with the direct-acting antivirals for hepatitis C.

Authors:  Alain Braillon
Journal:  Aust Prescr       Date:  2017-06-01

2.  Progress toward implementing the Swiss Hepatitis Strategy: Is HCV elimination possible by 2030?

Authors:  Beat Müllhaupt; Philip Bruggmann; Florian Bihl; Sarah Blach; Daniel Lavanchy; Homie Razavi; Sarah Robbins Scott; David Semela; Francesco Negro
Journal:  PLoS One       Date:  2018-12-31       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.